News from Max Neeman International A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

09 Jun, 2014, 11:42 ET Regulatory Draft Gazette (Released on 24th April 2014) Addresses Medical Management of Injury Related to Clinical Trials in India

Max Neeman International announced today that India’s Ministry of Health released an amended draft gazette on medical management with regards...


03 Feb, 2014, 12:11 ET Regulatory Update on India Clinical Research Approval Timelines

 Dr. Renu Razdan, Vice President ACRO India and also the Chief Operating Officer, Max Neeman Medical International welcomes the new timelines...


05 Dec, 2013, 11:47 ET Dr. Renu Razdan of Max Neeman International Appointed Vice Chairman, ACRO India

The Association of Contract Research Organizations [ACRO] India has appointed Max Neeman's Chief Operating Officer, Dr. Renu Razdan as Vice...


14 Oct, 2013, 11:33 ET Dr. Renu Razdan of Max Neeman International Speaks at Lilly Women India Network Event

 Max Neeman International announced today that Chief Operating Officer, Dr. Renu Razdan was a guest speaker at the Lilly Women Network event in...


30 Jul, 2013, 10:19 ET Max Neeman International's COO, Dr. Renu Razdan published in BioSpectrum Citing Changes in India Clinical Research and Regulatory Environment

Max Neeman's COO, Dr. Renu Razdan published in BioSpectrum [July 2013]; a prominent industry magazine. As Max Neeman is the leading, local Indian...


27 Mar, 2013, 14:16 ET Max Neeman International Adds to Existing Six Sigma, SOP Training

 Max Neeman International, a leading Asia-Pacific CRO, has announced successful completion of its first MAXimizer project focused on the Data...


10 Oct, 2012, 11:50 ET Leading Indian CRO 'Max Neeman International' Expands Asia-Pacific Presence with New Sites in Bangladesh, Sri Lanka & Malaysia

 Max Neeman International now has a larger Asia-Pac footprint with new presence and capabilities in neighboring countries of Bangladesh, Sri...


23 Jul, 2012, 10:39 ET Leading India-USA based CRO Announces Data Management/EDC, Medical Writing Milestone

Max Neeman International announced today that they have provided Data Management services to over 60 countries and have completed 250 Medical...


05 Dec, 2011, 10:38 ET Leading Indian CRO 'Max Neeman International' Expands in Response to Positive Biosimilars Market in India

 A dedicated and experienced Max Neeman team has been set-up to conduct Biosimilar studies for evaluation and efficacy of products....


10 Nov, 2011, 11:10 ET Max Healthcare Announces Organizational Changes

Max Healthcare, India's first comprehensive provider of standardized, seamless and world-class healthcare services, today announced organizational...


17 Oct, 2011, 12:08 ET CTRI Confirms Leading Indian CRO Supports Majority of Hemophilia Trials in India

Max Neeman International is the only CRO in India to manage hemophilia trials according to the Clinical Trials Registry-India (CTRI). Of the total...


28 Sep, 2011, 10:29 ET Max Neeman International ISO 14155: 2011 Certified for Medical Device Trials

Max Neeman announces the grant of ISO 14155:2011 certificate; the only Indian CRO and one of only a few global CROs to be certified for design,...


01 Sep, 2011, 11:09 ET Max Neeman International Launches Customized Project Management Software for India-based Clinical Studies

Leading India-based CRO, Max Neeman International, creates and launches customized Project Management Software (PMS) to meet unique study needs...


17 Jun, 2011, 11:41 ET Max Institute of Minimal Access, Metabolic & Bariatric Surgery Accredited as an International Centre of Excellence for Minimal Invasive Surgery

Max Neeman International, leading Indian CRO, is part of the prestigious Max Group whose sister-company, Max Healthcare recently had one of 12...


03 May, 2011, 13:43 ET Max Neeman International Responds to New India Clinical Research Guidelines

The Drug Controller General of India (DCGI) has formed new Regulatory and ICH GCP guidelines.  These guidelines include: recommendations...


12 Apr, 2011, 10:54 ET Max Neeman International Completes Targeted Enrollment of 15,000 for Large Ph IV Study

Max Neeman meets enrollment and timeline of 15,000 for a large, Phase IV metabolic disorder trial across 1200 sites throughout India. As a leading...


01 Mar, 2011, 12:42 ET Max Neeman Develops Innovative Approach for Rare Disease Studies

Max Neeman International has established a team of experts specialized in carrying out rare disease trials in response to sponsor demand. The team...


14 Feb, 2011, 13:36 ET Max Neeman International Initiates Advisory Committee to Advance and Improve the Conduct of Complex Neurological Trials in India

India's premier CRO, Max Neeman, participated in the 59th annual Neurological Society of India & Congress of Neurological Surgeons (NEUROCON)...


26 Jan, 2011, 11:04 ET Over 200 Studies Awarded to India-Based CRO Max Neeman International

Max Neeman International, India's premier CRO, has quadrupled the amount of clinical trials awarded since 2007 and reached the milestone of over...


05 Jan, 2011, 11:56 ET Max Neeman International ISO 27001:2005 Certified for Information Security Management Systems

Max Neeman announces the grant of ISO 27001:2005 certificate; one of only a few Indian CROs to be certified for Information Security.  ...


01 Dec, 2010, 15:31 ET Chief Operating Officer of Leading India-based CRO, Max Neeman International Featured as One of India's 'Top 10 Women Achievers in Life Sciences Industry'

Max Neeman International announced today that Dr. Renu Razdan has been featured in the November issue of BioSpectrum India as a prominent female...


11 Oct, 2010, 12:19 ET India's Favorable and Progressive Regulatory Environment Causes Accelerated Growth of Max Neeman International's Regulatory Services

India has evolved into a preferred destination for conducting clinical trials in large part because the Indian Regulatory bodies have created an...


30 Sep, 2010, 12:00 ET Max Neeman International Initiates Large Phase IV Trial on Type II Diabetes with 25,000 Subjects Across 1,200 Sites

A global pharmaceutical company has initiated a prospective trial to evaluate the impact of insulin guidelines developed by the Indian National...


13 Sep, 2010, 16:11 ET Max Neeman International Expands Upon Cardiology and Device Trial Experience to Meet Increased Medical Device Development in India

Max Neeman International, a leading Indian CRO, announces the expansion of therapeutic focused device clinical trial services in India. Max Neeman...


13 Jul, 2010, 13:16 ET Max Neeman International Continues to Expand in Response to Increased Client Demand for Medical Writing Services

Max Neeman International, India's premier CRO, has expanded its team of medical writers in response to the growing demand for medical writing...